Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07311915 | Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study | not yet recruiting | N/A | 30 | Zhongda HospitalOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07318701 | Multi-agent LLMs for Decision Support in Cervical Cancer During Pregnancy | not yet recruiting | N/A | 150 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 0 | Jan 6, 2026 |
| clinicaltrials |
| NCT07310355 | 68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer | not yet recruiting | Phase 1 / Phase 2 | 49 | Chengdu StarRay Therapeutics Co., LtdINDUSTRY | 0 | Dec 30, 2025 | clinicaltrials |
| NCT07310433 | Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer | not yet recruiting | Phase 2 | 60 | Yung NAOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07300566 | Focal Versus Whole Gland High Dose-Rate Brachytherapy (HDR-BT) Boost to External Beam Radiotherapy in Localized Prostate Cancer: A Phase 2 Randomized Trial(FORWARD) | not yet recruiting | Phase 2 | 58 | Joelle HelouOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT06799624 | Prognostic Role of molEcular classiFication in Fertility-sparing treAtment of Endometrial canCEr(PREFACE) | not yet recruiting | — | 100 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT07280897 | SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial(SCIPI) | not yet recruiting | N/A | 200 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT07295132 | RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse) | not yet recruiting | Phase 2 | 160 | Asan Medical CenterOTHER | 0 | Dec 19, 2025 | clinicaltrials |
| NCT07291557 | PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer | not yet recruiting | Phase 2 | 250 | AHS Cancer Control AlbertaOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT07282197 | Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019 | not yet recruiting | Phase 2 | 40 | Peking University First HospitalOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT07069049 | Electroacupuncture in the Treatment of Patients Undergoing Transperineal Prostate Biopsy Under Local Anesthesia(EATPULA) | not yet recruiting | N/A | 190 | Shanghai University of Traditional Chinese MedicineOTHER | 0 | Dec 9, 2025 | clinicaltrials |
| NCT07272317 | PSMA-PET/MRI-Ultrasound Multimodal Fusion Navigation for Da Vinci Robot-Assisted Radical Prostatectomy: A Randomized Controlled Trial | not yet recruiting | N/A | 98 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT05077215 | Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer | not yet recruiting | Phase 3 | 450 | Evergreen Therapeutics, Inc.INDUSTRY | 0 | Dec 8, 2025 | clinicaltrials |
| NCT05106127 | Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem | not yet recruiting | Phase 2 | 28 | Evergreen Therapeutics, Inc.INDUSTRY | 0 | Dec 8, 2025 | clinicaltrials |
| NCT06637943 | Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy | not yet recruiting | — | 210 | Konkuk University Medical CenterOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT07268794 | CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer(CONVERT-HB1) | not yet recruiting | Phase 2 | 112 | Fudan UniversityOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT07269535 | A Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma | not yet recruiting | — | 500 | Tongji HospitalOTHER | 0 | Dec 8, 2025 | clinicaltrials |
| NCT07269574 | Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance | not yet recruiting | — | 600 | Tongji HospitalOTHER | 0 | Dec 8, 2025 | clinicaltrials |
| NCT07267780 | Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases. | not yet recruiting | — | 130 | National Cancer Institute, NaplesOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT07268469 | Minimal Residual Disease in Solid Malignancies(IMRD) | not yet recruiting | N/A | 840 | European Institute of OncologyOTHER | 0 | Dec 5, 2025 | clinicaltrials |
| NCT07256977 | Minimally Invasive Radical Hysterectomy Using Endoscopic Stapler in Stage IB2 or IIA1 Cervical Cancer(SOLUTION2) | not yet recruiting | N/A | 494 | Seoul National University HospitalOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07251829 | Neoadjuvant Embolization and Cytoreduction in Prostate Cancer | not yet recruiting | Phase 2 | 35 | Srinivas RamanOTHER | 0 | Nov 26, 2025 | clinicaltrials |
| NCT06400160 | Clinical Trial of TB511 in Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 12 | Twinpig Biolab, Inc.INDUSTRY | 0 | Nov 25, 2025 | clinicaltrials |
| NCT07249021 | This is a Multicentre International Study Evaluating CT-based IGABT With / Without Either TRUS During BT/Pre BT MR as Per IBS-GECESTRO-ABS Recommendations for Target contouring-as an Alternative to MRIGABT for Cervical Cancer From Implementation Perspectives Under EMBRACE-III:TRIPLET IMPACT Study.(IMPACT) | not yet recruiting | — | 1,200 | Homi Bhabha Cancer Hospital & Research CentreOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT07244393 | Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer | not yet recruiting | Phase 1 | 30 | Cellbion Co., Ltd.INDUSTRY | 0 | Nov 24, 2025 | clinicaltrials |
| NCT07244965 | Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer | not yet recruiting | Phase 2 | 42 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07245342 | Electroacupuncture for Improving Urinary Incontinence After Radical Prostatectomy(EA) | not yet recruiting | N/A | 216 | Shanghai University of Traditional Chinese MedicineOTHER | 0 | Nov 24, 2025 | clinicaltrials |
| NCT07057167 | Prediction of Ovarian Cancer Histotypes and Surgical Outcome(PANtHer-AI) | not yet recruiting | — | 100 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | Nov 20, 2025 | clinicaltrials |
| NCT07238959 | Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer | not yet recruiting | — | 1,100 | Shanghai Changzheng HospitalOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT07239518 | A Prospective Evaluation of Early Acupuncture for Immediate Continence Enhancement After Prostatectomy(PEACE) | not yet recruiting | N/A | 144 | Bin XuOTHER | 0 | Nov 20, 2025 | clinicaltrials |
| NCT07239622 | Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma | not yet recruiting | Phase 2 | 36 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Nov 20, 2025 | clinicaltrials |
| NCT07164794 | Memantine Hydrochloride in Prostate Cancer Patients | not yet recruiting | Phase 2 | 15 | Bin XuOTHER | 0 | Nov 19, 2025 | clinicaltrials |
| NCT07230444 | Artificial Intelligence for the Intra-procedural Assessment of Uterine Artery Embolization(AI-EMBO) | not yet recruiting | — | 250 | Emanuele BarabinoOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT07235787 | Efficacy of Ultrasound Guided Microwave Ablation in the Treatment of Uterine Fibroids.(MWAUF) | not yet recruiting | N/A | 20 | Jihad Hussien Mohamed MahmoudOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT07234097 | The Influence of Music on perceiVed paIn and leVels of Anxiety whiLe unDergoing transperIneal Prostate Biopsy: the VIVALDI Trial(VIVALDI) | not yet recruiting | N/A | 78 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOTHER | 0 | Nov 18, 2025 | clinicaltrials |
| NCT07230626 | SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer | not yet recruiting | Phase 3 | 412 | CSPC Megalith Biopharmaceutical Co.,Ltd.INDUSTRY | 0 | Nov 17, 2025 | clinicaltrials |
| NCT06536374 | Folate Study in Men With Advanced Prostate Cancer | not yet recruiting | Phase 2 | 50 | University of California, San DiegoOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT07226037 | Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC)(DOSE-CC) | not yet recruiting | N/A | 80,000 | Boston Medical CenterOTHER | 0 | Nov 10, 2025 | clinicaltrials |
| NCT07213427 | Outcomes of Image-guided High-dose-rate Uterovaginal Brachytherapy With Single Implantation(UNICURE-HD) | not yet recruiting | — | 363 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Oct 8, 2025 | clinicaltrials |
| NCT07210502 | Side Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate Cancer(LDR BURST) | not yet recruiting | N/A | 220 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT06861855 | Prognosis of METTL-14 in Endometrial Carcinoma | not yet recruiting | — | 50 | Assiut UniversityOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT04993508 | Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging(PRIMA) | not yet recruiting | N/A | 1,908 | Heinrich-Heine University, DuesseldorfOTHER | 0 | Sep 26, 2025 | clinicaltrials |
| NCT07088731 | Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer | not yet recruiting | Phase 2 | 180 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT07186868 | QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer | not yet recruiting | — | 25 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | Sep 22, 2025 | clinicaltrials |
| NCT06663553 | Comparing the Efficacy of TU-LESS and vNOTES for Hysterectomy of Enlarged Uterus | not yet recruiting | N/A | 210 | West China Second University HospitalOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT07177534 | Prospective Validation Study of a Uterine Fibroid-Related Infertility Prediction Model | not yet recruiting | — | 7,084 | Tongji HospitalOTHER | 0 | Sep 17, 2025 | clinicaltrials |
| NCT07177716 | Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer | not yet recruiting | Phase 2 / Phase 3 | 120 | L & L Bio Co., Ltd., Ningbo, ChinaINDUSTRY | 1 | Sep 17, 2025 | clinicaltrials |
| NCT07172126 | Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets | not yet recruiting | Phase 1 / Phase 2 | 291 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07172217 | The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC | not yet recruiting | Phase 2 | 33 | Qilu Hospital of Shandong UniversityOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07170982 | Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer | not yet recruiting | Phase 2 | 128 | Sun Yat-sen UniversityOTHER | 1 | Sep 12, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jan 6, 2026source: clinicaltrials